尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Nunes Anne. Insider active across 1 company, notably Anika Therapeutics, Inc.. In total, 7 disclosures have been logged. Activity tracked since 1 October 2023. The latest transaction was filed on 17 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Nunes Anne is an insider linked to Anika Therapeutics, Inc., where she holds the role of SVP, Chief Operations Officer. She has 7 filings in total, and in the recent filings tracked, the most common transaction nature is option exercise, with a period ranging from 2023-10-03 to 2025-03-18.